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doi:10.1016/j.jfma.2010.10.001Background/Purpose: In influenza B infection, viral load is believed to be related to the
severity of clinical illness. The correlation between viral load and symptoms is not known.
We conducted a study to assess the relationship between virus load and clinical features in
children infected with influenza B, in the hope that clinical features could be used as surrogate
markers of viral load to guide treatment.
Methods: Between December 2006 and February 2007, 228 patients with fever and respiratory
symptoms were prospectively enrolled in our tertiary hospital-based study. Real-time reverse
transcription polymerase chain reaction (RT-PCR) was performed to determine viral load.
Results: Real-time RT-PCR was positive for influenza B in 76 patients. Using virus culture as the
gold standard, the sensitivity and specificity were 95% and 87%, respectively. Influenza culture
positive rate significantly correlatedwith viral load (pZ 0.03). Themedian copy number of influ-
enza B virus in the 76 RT-PCR positive patients was 9735 copies/ml (range 4.8101e2.0106
copies/ml). Samples obtained later in the clinical course tended to have lower viral loadnterest, real or perceived. The study sponsor had no involvement in the study design, collection,
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84 T.-P. Tsou et al.(pZ 0.7), while patient age (pZ 0.72) and fever duration (pZ 0.96) positively related to viral
load. In patients >3 years of age, myalgia was related to statistically lower viral loads (14300 vs.
1180; pZ 0.025). Patients with chills tended to have higher viral loads (72450 vs. 7640; pZ 0.1).
Patients with abdominal pain tended to have lower viral loads (1998 vs. 12550; pZ 0.06).
Conclusion: Culture rate positively correlated with viral load. Patients with myalgia had a lower
viral load.
Copyright ª 2012, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Introduction
Influenza is a common disease, which is associated with
outpatient visits, hospitalizations, morbidity, and mortality
in children.1 It has a short incubation period and is easily
transmitted. Effective medication, rapid diagnosis, and
timely intervention are of vital importance to the public.2
Since the development of polymerase chain reaction
(PCR) analysis in 1985, the sensitivity and speed of diag-
nosing various virus infections, including influenza, has
been much improved.2
Real-time PCR, which allows the assessment of the
amount of virus at a given point in time, has been used
extensively to determine the dynamics of diseases caused
by viral infections such as hepatitis B and human immuno-
deficiency virus (HIV).3,4 Studies investigating the rela-
tionship between viral load and the disease course of
natural human influenza infection have been limited to
immunocompromised patients, H5N1 avian influenza, and
pandemic H1N1.5e8 This present study collected data
regarding influenza B viral load, during natural infection in
children, and investigated how viral load correlates with
clinical manifestations of the disease.
Materials and methods
In the peak of the 2006/2007 influenza season, between
December 8, 2006 and February 8, 2007, we enrolled 228
patients <18 years old with influenza-like illnesses (ILI)
who visited either the pediatric outpatient clinic, emer-
gency departments, or were admitted to National Taiwan
University Hospital, a tertiary hospital in Taiwan. ILI was
defined as the presence of fever (tympanic temperature
38C), plus any respiratory symptoms or signs. All patients
or their parents gave written informed consent. Two throat
swabs were taken from each patient: one for real-time
reverse-transcriptase-PCR (RT-PCR) in our research lab, and
one for virus culture in the central lab. For patients with
positive results for influenza B virus (isolated virus or
positive real-time RT-PCR), we analyzed their clinical
manifestations, contact and vaccine history, diagnosis, and
treatment by a review of their medical records. Pneumonia
was diagnosed by positive radiological findings or notes
recorded on patient charts. Sinusitis was diagnosed by
clinical manifestations of purulent rhinorrhea, sinus
tenderness, and/or haziness of the sinuses on sinus X-ray.
Acute otitis media (AOM) was diagnosed by the presence of
congested ear drums with or without effusion.
For virus isolation, throat swab samples were inoculated
into human embryonic fibroblast (MRC-5), LLC-MK2, HEp-2,and RD cell cultures. Once cytopathic effects appeared,
fluorescent antibody staining was used to confirm the
presence of the influenza B virus. For real-time RT-PCR,
RNA extraction from the throat swabs was performed using
a viral RNA extraction kit in accordance with the manu-
facturer’s instructions (QIAamp Viral RNA Mini Kit, Qiagen,
Hilden, Germany). Light cycle real-time RT-PCR was used to
detect influenza B viruses. Primer and probe sequences
based on the HA gene, 50-AAATACggTggATTAAATAAAAgCAA-
30, 50-CCAgCAATAgCTCCgAAgAAA-30, and the probe 50-6FAM-
CACCCATATTgggCAATTTCCTATggC eTMR-30, were used.
RT-PCR was performed at 61C for 20 minutes, denaturing at
95C for 30 seconds, 50 cycles of 95C for 1 second, 56C for
15 seconds, 72C for 15 seconds, and cooling at 40C for 30
seconds. Any copy number detected was considered a posi-
tive PCR result.
Chi-square or Fisher’s exact test was used to analyze
categorical data. Mann-Whitney U test was used for
continuous variables not normally distributed. Linear
regression was used for correlation analysis. All p values
were two-tailed, and p values less than 0.05 were consid-
ered to be statistically significant. SPSS 14.0 (SPSS, Inc.,
Chicago IL) was used for statistical analysis.
Results
Sensitivity and specificity of influenza PCR
Real-time RT-PCR was positive for influenza B in 76/228
patients. Fifty-six were both RT-PCR and culture positive.
Three culture-proven influenza B patients had negative RT-
PCR results. Twenty patients were RT-PCR positive/culture
negative. Among them, two were found to be culture
positive for herpes simplex virus type 1 (HSV-1), one for
cytomegalovirus (CMV), and one for parainfluenza virus
type 3. No viruses could be isolated in the remaining
influenza B RT-PCR positive/culture negative patients.
Seventeen patients tested positive for influenza A by RT-
PCR and culture (n Z 15), or culture only (n Z 2). Among
those negative for both RT-PCR and culture, 34 specimens
were culture positive for other pathogens including respi-
ratory syncytial virus (n Z 8), adenovirus (n Z 11), para-
influenza virus (nZ 5), non-polio enterovirus (nZ 5), CMV
(n Z 3), and HSV-1 (n Z 2).
Using viral isolation as the gold standard, any copy
number found by real-time RT-PCR had a 95% sensitivity and
87% specificity in detecting influenza B. Influenza culture
positive rate significantly and positively correlated with
viral load (Fig. 1; p Z 0.03). The specificity would be
increased to 89% if a cut-off viral load of 102 is used,
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Figure 1 Virus culture result and its relationship with viral
load in throat swab specimens from children infected with
influenza B (N Z 76). Viral load is positively correlated with
culture positive rate (p Z 0.03 by linear regression analysis).
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Figure 2 Correlation of viral load with sample time in chil-
dren infected with influenza B (nZ 76). The day of fever onset
was defined as day 1. Correlation of viral load in throat swab
specimen with sample time after fever onset (r2 Z 0.002;
p Z 0.7).
Influenza B and viral load in children 85whereas the sensitivity remained unchanged. The speci-
ficity would further increase to 94% where a cut-off viral
load of 103 is used, but here the sensitivity would be
decreased to 83%.
Demographic data and clinical manifestations of
patients
We further analyzed the demographic and clinical data of
79 patients with influenza B, diagnosed either by culture or
RT-PCR. Their median age was 7 years (range 9 monthse17
years 11 months). Patients aged <5 years, between 5 years
and 10 years, and >10 years, accounted for 33%, 42%, and
25% of all patients, respectively. Forty-eight (61%) patients
were male.
Thirty-two percent of influenza positive patients (25/79)
had contacted at least one symptomatic household member
before symptom onset. Among them, 18 (72%) had family
members with upper respiratory tract symptoms. Seven
(28%), had family members with ILI. Most of the household
contacts were brothers or sisters (19/25). Others were
parents (n Z 3) or grandparents (n Z 3).
The most common initial diagnoses of these patients
were influenza or ILI (53%) and pneumonia (18%). The most
common signs and symptoms were rhinorrhea (77%), cough
(71%), and throat injection (60%). Forty-one patients had
their fever duration recorded and the median was 4 days
(range 1e9 days).
Vaccination history
Ten (13%) patients had received at least one dose of influ-
enza vaccine in the 2006/2007 season and all were younger
than 8 years old. Three patients had received a complete
two-dose vaccination course. Patients who were vaccinated
were significantly younger than those who were not
(median age Z 30 vs. 98 months; Mann-Whitney U test,
p Z 0.001).
Disposition, treatment, and complications
Twenty percent of all patients (16/79) were hospitalized for
a median of 6.5 days (range 1e20 days). Two patients hadbeen admitted to the intensive care unit because of severe
pneumonia and empyema. Oseltamivir (Tamiflu) had been
given to seven patients. The duration of treatment ranged
between 4 days and 7 days.
The most common complication was pneumonia (24%).
Twenty-four patients underwent chest X-ray examination.
Imaging studies showed lung consolidation in four, including
one with a group A b-hemolytic streptococcal empyema
who had undergone video-assisted thoracoscopic surgery.
Other complications included sinusitis (20%) and AOM (10%).
In multivariate analysis, consolidation on chest X-ray was
the only factor that significantly affected the decision to
admit a patient (p < 0.01).
Viral load
Defining the day of fever onset as day 1, the median sample
time was day 3 (range 1e11). Fifty-six percent (44/79) of
the samples were obtained within 3 days of fever onset.
The median copy number of influenza B virus in the 76
RT-PCR positive patients was 9,735 copies/ml (range 48e2 
106 copies/ml). There was a trend to suggest that sample
time negatively correlated to viral load (Fig. 2; r2Z 0.002;
pZ 0.7). Patient age (correlation coefficientZ 0.041; pZ
0.72) and fever duration (correlation coefficient Z 0.006;
p Z 0.96) positively correlated with viral load.
Apart for patients with myalgia who had lower viral loads
(median valuesZ 2,440 vs. 13,000; pZ 0.04), viral load did
not differ between patients with different clinical mani-
festations and demographics (Table 1). Because myalgia is
a subjective complaint that is more common in older chil-
dren (median age Z 110 vs. 83 months; p Z 0.04 [Mann-
Whitney U test]), we further stratified patients with
myalgia into different age groups (3 years and >3 years)
and compared their viral loads. There were 14 and 62
patients in each age group, respectively. Only in patients
>3 years old did myalgia relate to a statistically lower viral
load (14,300 vs. 1,180; p Z 0.03 by Mann-Whitney U test).
For patients >3 years old, we further stratified them by
sample day. Among all samples taken 3 days after fever
onset, myalgia was significantly associated with lower viral
loads (p Z 0.047 by Mann-Whitney U test). Patients with
chills tended to have higher viral loads (72,450 vs. 7,640),
Table 1 Median viral load (VLM) according to clinical
features (N Z 76).
Variable VLM with this
feature (case
number)
VLM without this
feature (case
number)
p
value
Male 9325 (46) 13,050 (30) 0.20
Influenza vaccine 12,550 (10) 9325 (66) 0.81
Admission 9900 (15) 9570 (61) 0.60
Complications 14,950 (36) 8480 (40) 0.76
Use of oseltamivir 9080 (7) 9900 (69) 0.96
Household contact 9080 (25) 9900 (51) 0.64
Rhinorrhea 9570 (57) 10,500 (19) 0.90
Cough 8480 (66) 17,100 (10) 0.25
Sore throat 19,050 (16) 8480 (60) 0.38
Hoarseness 7200 (3) 9900 (73) 0.93
Calf pain 8840 (18) 12,100 (56) 0.60
Myalgia 2400 (14) 13,000 (62) 0.04*
Chills 72,450 (10) 7640 (66) 0.10
Headache 15,300 (11) 9570 (65) 0.87
Abdominal pain 1998 (8) 12,550 (68) 0.06
Vomiting 15,300 (7) 9080 (69) 0.87
Diarrhea 16,600 (10) 9325 (66) 0.87
*Statistically significant by Mann-Whitney U test.
86 T.-P. Tsou et al.whereas patients with abdominal pain tended to have lower
viral loads (1,998 vs. 12,550), but these differences did not
reach statistical significance.
Discussion
The sensitivity and specificity of influenza PCR varies in
different studies, depending on the technique, patient
population, and gold standard used.9 The sensitivity and
specificity of our influenza RT-PCR is similar to that re-
ported in other series.10 Detection methods using conven-
tional cultures have always had some disadvantages due to
the lack of speed and the little impact on patient care. In
previous studies, culture positive rate was found to be
associated with semi-quantitative results of RT-PCR when
comparing the cycle threshold value.9,11 Higher viral load
was consistently found in culture-positive samples,
although the statistical significance had never been proved.
Our study clearly demonstrates the correlation between
viral load and a positive viral culture. In our study, samples
with copies of viral RNA fewer than 1000 would not yield
a positive culture result in more than half of cases. Because
the presence of viral genome does not necessarily mean
that there are replication-competent viruses in the clinical
samples, this discrepancy is understandable. We believe
that positive RT-PCR results in patients with clinical symp-
toms of influenza indicate active infection.
In our study, real-time RT-PCR detected influenza in 56
of 59 culture-positive samples, and resulted in 20 additional
positives. Because all of these patients had fever and
respiratory symptoms, these 20 cases are unlikely to be
false positives. Five of these patients were also culture
positive for other pathogens. Because no typical symptoms
of CMV or HSV infection were recorded in these patients,the presence of CMV and HSV may reflect colonization
rather than true infection. The patient who was RT-PCR
positive for influenza B and culture positive for para-
influenza virus type 3 may had dual infection, which is not
a rare condition.12 Three patients were RT-PCR negative,
but culture positive. In a previous study comparing RT-PCR
with conventional culture, viral genome was detected by
RT-PCR in eight out of nine culture-positive specimens.9
Because no single test is 100% sensitive and specific,
based on the results of our study, and also clinical experi-
ence, we believe that RT-PCR complements, rather than
replaces, conventional culture as a diagnostic tool.
The low hospitalization rate (around 20%) reflects the
outpatient source of our patients. Apart from younger
age,13 radiographic findings of pulmonary consolidation is
also a risk factor for hospitalization. Pulmonary complica-
tions can be caused by influenza virus itself, by secondary
bacterial infection, or both.13 Streptococcus pneumoniae
and Staphylococcus aureus are the bacterial pathogens
most commonly identified.14e16 Group A b-hemolytic
streptococcus has also been reported.15 As we had only one
patient who had undergone invasive diagnostic procedures,
the bacterial etiology remained unknown in most subjects.
The viral kinetics of influenza virus A infection within an
individual has been previously studied using experimental
infections.17,18 There is also a significant correlation
between viral titers and cytokine levels, which reportedly
peaks at different days after infection.18 In natural infec-
tions, the virus load can be affected by different inocula-
tion routes and amount, as well as patient age, and their
general health condition. In a recent study on viral load in
patients infected with pandemic H1N1 influenza A pub-
lished by To et al, serial samples were taken from patients
hospitalized for pandemic H1N1, and viral load was found
to be negatively correlated with time after symptom
onset.8 The correlation between virus load and days after
infection was not as clearly identified in our study because
we did not have serial samples from the same patient.
Serial viral load monitored in each patient with simulta-
neous cytokine assays will help us understand more about
the viral kinetics of natural infection and the host response.
Lack of serial sampling is the main limitation of our study,
but our setting is more similar to the situation found in daily
practice.
In order to find any clinical parameter that could predict
a higher viral load and help in clinical decision-making, we
attempted to find the correlation between viral load and
various clinical manifestations. In patients older than 3
years, in whom we assume that subjective complaints are
more reliable, complaints of myalgia were associated with
a lower viral load, irrespective of sample day. In a study
focusing on the relationship between cytokine responses,
viral load and clinical symptoms of experimental human
influenza A virus infection in 20 adult volunteers, viral load
and systemic symptoms, such as fever and muscle ache,
both peaked at the second day of infection.18 Serum level
of interleukin (IL) peaked on the second day, whereas
tumor necrosis factor (TNF) peaked at the 4th day, when the
severity of systemic symptoms also decreased.18 In the
above study, the severity score of all systemic symptoms
(muscle aches, fatigue, headache, and fever) were
combined as a generalized indicator of the severity, which
Influenza B and viral load in children 87made the assessment of individual symptoms unfeasible.
As myalgia was purported to be caused by TNF and pros-
taglandin,19 it is reasonable to assume that the presence of
myalgia is associated with higher level of TNF and a lower
viral load. The trend of chills associating with a higher viral
load can also be explained by the effect of IL on fever/
chills.19
In summary, this study defines the correlation between
viral load and culture positivity. We also suggest that
myalgia is an indicator of a lower viral load in patients. The
usefulness of clinical manifestations as surrogate markers
of infection severity to guide clinical treatment is worthy of
further investigation.Acknowledgments
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